Marksans Pharma Ltd. (INR)257.99.4 (3.8%)
Exchange ScripsBSE524404NSEMARKSANSISININE750C01026
Indicators | Value | Signal |
---|---|---|
5-DMA | 264.97 | Bearish |
10-DMA | 280.09 | Bearish |
20-DMA | 291.2 | Bearish |
50-DMA | 307 | Bearish |
100-DMA | 291.35 | Bearish |
200-DMA | 232.26 | Bullish |
Field | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
---|---|---|---|---|---|
Promoters | 2 | 2 | 2 | 2 | 2 |
Foreign Investors | --- | --- | --- | --- | --- |
Domestic Investors | 2 | 2 | 2 | 2 | 2 |
Public Investors | 259811 | 248843 | 235498 | 254697 | 237375 |
Government | --- | --- | --- | --- | --- |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Other Income | 504 | 593 | 419 | 67 |
Operating Profit | 5090 | 3986 | 3007 | 3463 |
Interest | 112 | 91 | 84 | 80 |
Depreciation | 743 | 519 | 448 | 362 |
Profit Before Tax | 4235 | 3377 | 2475 | 3022 |
Consolidated Net Profit | 3137 | 2663 | 1846 | 2359 |
Adjusted EPS | 7 | 6 | 5 | 6 |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Share Capital | 453 | 453 | 409 | 409 |
Total Reserves | 20197 | 16998 | 10682 | 8456 |
Minority Interest | 209 | 199 | 207 | 189 |
Total Non-Current Liabilities | 2052 | 843 | 571 | 237 |
Total Liabilities | 26810 | 21904 | 16601 | 12280 |
Capital Work in Progress | 54 | 72 | 7 | 56 |
Total Assets | 26810 | 21904 | 16601 | 12280 |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Cash Flow from Operating Activities | 2304 | 2374 | 993 | 1786 |
Cash Flow from Investing Activities | -1408 | -2592 | -844 | -448 |
Cash Flow from Financing Activitie | -687 | 1978 | 795 | -153 |
Net Cash Inflow / Outflow | 208 | 1760 | 944 | 1185 |
Marksans Pharma Ltd.
257.99.4 (3.8%)
Symbol | Change% |
---|---|
BRNL | 47.17(20%) |
SURYAROSNI | 280.05(20%) |
ADANIPOWER | 537(19%) |
KHANDSE | 29.12(19%) |
IOB | 53.77(18%) |
Announcing Stock of the Month!